TCL Archive “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor November 8, 2013
TCL Archive Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel April 5, 1974
TCL Archive NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate October 22, 1993
TCL Archive In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte March 8, 1991